Press release
Artificial Disc Replacement Market is Expected to Reach USD 1.38 billion by 2029 at a CAGR of 11.8%
Artificial Disc Replacement Market 2022
In 2022, the Artificial Disc Replacement Market stands at USD 636.7 million, and it is expected to reach USD 1,388.6 million by 2029 at a CAGR of 11.8%. An increase in the adoption of artificial discs and the increasing demand for outpatient surgeries along with the technological advancements are the key factors driving the growth of the market.
Get Free Sample Copy Of Umbilical Cord Blood Banking Market Report@ https://www.persistencemarketresearch.com/samples/3043
According to a new market report published by Persistence Market Research "Global Market Study on UCB Banking - Asia-Pacific to Witness Highest Growth by 2020" the global UCB banking market is estimated at USD 13,515.8 million in 2014 and is expected to grow at a CAGR of 6.1% from 2014 to 2020, to reach an estimated value of USD 19,335.6 million in 2020.
The UCB banking market is witnessing a significant growth due to the increasing prevalence of chronic diseases coupled with regenerative medicines. In addition, initiatives by various government associations have increased the importance of UCB by rising awareness about potential applications of cord blood are also supporting in the growth of the global UCB banking market.
Some of the major players operating in the UCB banking market:
Cord Blood Registry Systems, Inc.
Cordlife Group Limited.
Cord Blood America, Inc.
NeoStem Inc.
Cryo-Cell International, Inc.
ViaCord.
Esperite NV.
Smart Cells International Ltd.
China Cord Blood Corporation.
Request For Customization@https://www.persistencemarketresearch.com/request-customization/19723
However, strict license and accreditation procedures and high cord blood banking fee in private banks hampers the growth of global UCB banking market. As a result, the global UCB banking market is expected to grow a CAGR of 6.1% during 2014-2020.
North America has the largest market for UCB banking. Increasing prevalence of chronic diseases is key driver of UCB banking market in the region. In addition, various government associations have also led to the importance of cord blood donation and services for its future use in North America.
Similarly, the European UCB banking market is mainly driven by the increasing prevalence of diseases. In addition, increased awareness about therapeutic applications of cord blood and rising number of live births are also contributing in the growth of the UCB market in the region.
In Asia-Pacific, UCB banking market is growing due to rising aging population and increasing prevalence of chronic diseases. In addition, several government associations and increasing number of live births are also increasing the demand of cord blood banking services in the region.
Go To "Purchase Now" To Have Our Umbilical Cord Blood Banking Market Report@ https://www.persistencemarketresearch.com/checkout/3043
Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Araia, South Africa etc.)
Related Reports:
Botulinum Toxin Market -https://www.persistencemarketresearch.com/market-research/botulinum-toxin-market.asp
The global botulinum toxin market is valued of US$ 5.5 Bn at present, and is set to expand at a CAGR of 6.9%, and reach a valuation of US$ 10.7 Bn by 2031.
Scar Treatment Market -https://www.persistencemarketresearch.com/market-research/scar-treatment-market.asp
Global scar treatment market expects the market to see moderate CAGR growth between 2017-2025 and likely to bring in US$ 13,106 Mn revenue by 2025 end.
Contact us:
Persistence Market Research
Address - 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com
About Us :-
Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers' experience by acting as the "missing" link between "customer relationships" and "business outcomes'. The best possible returns are assured therein.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Artificial Disc Replacement Market is Expected to Reach USD 1.38 billion by 2029 at a CAGR of 11.8% here
News-ID: 2735863 • Views: …
More Releases from Persistence Market Research
Aseptic Packaging Market Set to Grow to US$136.5 Bn by 2033 Driven by Rising Foo …
Introduction: Aseptic Packaging Market Overview and Industry Evolution
The aseptic packaging market has emerged as a cornerstone of modern food, beverage, and pharmaceutical preservation systems. As global consumers increasingly seek safe, long-lasting, and convenient packaged products, aseptic packaging solutions have gained substantial importance. This technology allows products to be sterilized separately from packaging materials and filled in a sterile environment, ensuring extended shelf life without refrigeration or preservatives. The rising demand…
Gas-Insulated Transmission Line (GIL) Market Expected to See Growth to US$836.9 …
Introduction: Rising Demand for Advanced Power Transmission Solutions
The global energy landscape is undergoing a major transformation as nations accelerate investments in renewable energy, grid expansion, and reliable electricity distribution networks. With rapid urbanization, industrialization, and digital infrastructure growth, the demand for uninterrupted and efficient power transmission has never been higher. Traditional overhead transmission systems, while widely used, face challenges related to land constraints, environmental exposure, and transmission losses. This has…
Dimethyl Sulfide (DMS) Market Anticipated to Reach US$ 251.2 Mn by 2033, Driven …
Market Overview: Expanding Demand for Dimethyl Sulfide Across Industries
The Dimethyl Sulfide (DMS) market is witnessing consistent growth due to its widespread applications across food processing, pharmaceuticals, agriculture, and chemical manufacturing. Dimethyl sulfide is an organosulfur compound known for its distinctive odor and reactive properties, making it a crucial intermediate in multiple industrial processes. In food and beverage applications, it is valued for flavor enhancement, while in chemical manufacturing, it serves…
Onyx Stone Market to Surge to Reach US$ 1.8 Bn by 2033 Driven by Construction & …
Market Overview: Rising Demand for Premium Natural Stones
The onyx stone market has gained remarkable prominence in recent years, driven by increasing demand for luxury natural stones in architecture, interior décor, and artistic applications. Onyx, known for its translucent appearance and unique veining patterns, has become a preferred choice for premium residential and commercial projects. The material's ability to elevate aesthetic appeal while maintaining durability has attracted designers, architects, and homeowners…
More Releases for UCB
Epilepsy Market Expected to Gain Momentum Through 2034, According to DelveInsigh …
The Key Epilepsy Companies in the market include - Aquestive Therapeutics, Atnahs Pharma (Pharmanovia), Jazz Pharmaceuticals, SK Biopharmaceutical, Angelini Pharma/Ono Pharmaceutical, Novartis, Xenon Pharmaceuticals, Takeda, Ovid Therapeutics, Biohaven Pharmaceuticals/Knopp Biosciences, and others.
DelveInsight's "Epilepsy Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Epilepsy, historical and forecasted epidemiology as well as the Epilepsy market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom…
Epilepsy Market Dynamics Indicate Upward Trajectory Through 2034, Reports DelveI …
The Key Epilepsy Companies in the market include - Aquestive Therapeutics, Atnahs Pharma (Pharmanovia), Jazz Pharmaceuticals, SK Biopharmaceutical, Angelini Pharma/Ono Pharmaceutical, Novartis, Xenon Pharmaceuticals, Takeda, Ovid Therapeutics, Biohaven Pharmaceuticals/Knopp Biosciences, and others.
DelveInsight's "Epilepsy Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Epilepsy, historical and forecasted epidemiology as well as the Epilepsy market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom…
Fibromyalgia Market to Exhibit Rapid Growth Rate During the Forecast Period (202 …
DelveInsight's "Fibromyalgia Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Fibromyalgia, historical and forecasted epidemiology as well as the Fibromyalgia market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Fibromyalgia market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Fibromyalgia Market Forecast
https://www.delveinsight.com/sample-request/fibromyalgia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the key facts of the Fibromyalgia…
Anticonvulsant Market - Functional Survey 2025 | GlaxoSmithKline Inc., UCB Group
Anticonvulsant Market for Fibromyalgia: Snapshot
Anticonvulsants are pharmacological agents from a diverse group that are used for the treatment of epileptic seizures. Anticonvulsants are increasingly in demand on account of their use for the treatment of bipolar disorders. They are also used for the treatment of borderline personality disorder. Anticonvulsants act as stabilizers of mood and helps in the treatment of neuropathic pain. They suppress the rapid, excessive firing of neurons…
Epilepsy Drugs Market 2017- UCB, EISAI, Pfizer
Epilepsy Drugs Market is likely to reach nearly USD 5.5 Billion by the year end of 2021.
Market growth can be attributed to factors such as rising incidence of neurological disorders, growing disease awareness, introduction of novel antiepileptic drugs (AEDs), strong government support and initiatives. Moreover, increasing R&D investment and launch of extended-release formulations are further expected to fuel the market growth. However, high cost of patented drugs, concerns over decreasing…
Global Stem Cell UCB Market Research Report 2016
Global Stem Cell UCB Industry 2016 Market Overview, Size, Share, Trends, Analysis, Technology, Applications, Growth, Market Status, Demands, Insights, Development, Research and Forecast 2016-2020.
The market intelligence publication delves into the condition of the global Stem Cell UCB market. An in-depth examination of the existing market state, past progress, and forthcoming prospects of the global Stem Cell UCB market has been presented in the research report. The research publication also reports…
